Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,204,528
+$292,773 QoQ
Shares Held
22,138
+4.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#318
of 751 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bull Harbor Capital LLC holds $7,168,026 across 12 Biotechnology names. EXEL ranks #2 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
14,967 | $1,696,659 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
22,138 | $1,204,528 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,594 | $993,922 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
14,406 | $824,311 | |
| 5 | RPRX |
Royalty Pharma plc
|
9,650 | $541,075 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
796 | $395,397 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
11,332 | $378,375 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,202 | $365,363 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,204,528 | 22,138 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $911,755 | 21,258 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||